What is the analyst consensus rating for APLS?

The analyst consensus rating for APLS is "Hold" based on 24 analyst recommendations.

What is the average price target for APLS?

The average 12-month price target for APLS is $37.33, representing a downside of 7.6% from the current price of $40.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Apellis Pharmaceuticals, Inc. (APLS) Forecast: Analyst Ratings & Targets

Latest APLS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Apr 2, 2026	Graig Suvannavejh	Mizuho	Maintains	Hold	$20.00 → $41.00 +21.00 (105.0%)
Apr 1, 2026	Google Biotechnology	TipRanks - Google	Downgrades	Buy	$18.00 → $44.00 +26.00 (144.4%)
Apr 1, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Hold	$18.00 → $43.00 +25.00 (138.9%)
Apr 1, 2026	Anthropic Biotechnology	TipRanks - Anthropic	Reiterates	Hold	$17.50 → $44.00 +26.50 (151.4%)
Apr 1, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Hold	$17.50 → $41.00 +23.50 (134.3%)
Apr 1, 2026	Steve Seedhouse	Cantor Fitzgerald	Downgrades	Hold	-
Apr 1, 2026	Douglas Tsao	HC Wainwright	Downgrades	Hold	$48.00 → $41.00 -7.00 (-14.6%)
Apr 1, 2026	Eliana Merle	Barclays	Maintains	Hold	$24.00 → $41.00 +17.00 (70.8%)
Apr 1, 2026	Anupam Rama	JP Morgan	Downgrades	Hold	$37.00 → $41.00 +4.00 (10.8%)
Apr 1, 2026	Yigal Nochomovitz	Citi	Downgrades	Hold	$44.00 → $41.00 -3.00 (-6.8%)
Apr 1, 2026	Colleen M. Kusy	Baird	Upgrades	Hold	$41.00
Apr 1, 2026	Ryan Deschner	Raymond James	Downgrades	Hold	-
Mar 31, 2026	Steven Seedhouse	Cantor Fitzgerald	Upgrades	Hold	$31.00
Mar 31, 2026	Lachlan Hanbury Brown	William Blair	Upgrades	Hold	$40.00 → $41.00 +1.00 (2.5%)
Mar 31, 2026	Akash Tewari	Jefferies	Upgrades	Hold	$41.00
Mar 31, 2026	Yigal Nochomovitz	Citi	Upgrades	Hold	$44.00 → $41.00 -3.00 (-6.8%)
Mar 31, 2026	Joseph Stringer	Needham	Downgrades	Hold	-
Mar 31, 2026	Judah Frommer	Morgan Stanley	Initiates Coverage	Hold	$25.00 → $41.00 +16.00 (64.0%)
Mar 18, 2026	Steve Seedhouse	Cantor Fitzgerald	Maintains	Buy	$35.00 → $31.00 -4.00 (-11.4%)
Mar 13, 2026	Adam Walsh	Roth Capital	Initiates	Strong Buy	$31.00
Mar 5, 2026	Graig Suvannavejh	Mizuho	Maintains	Hold	$19.00 → $20.00 +1.00 (5.3%)
Mar 5, 2026	Anupam Rama	JP Morgan	Maintains	Buy	$36.00 → $37.00 +1.00 (2.8%)
Feb 25, 2026	Laura Chico	Wedbush	Maintains	Hold	$20.00 → $18.00 -2.00 (-10.0%)
Feb 25, 2026	Douglas Tsao	HC Wainwright	Maintains	Strong Buy	$45.00 → $48.00 +3.00 (6.7%)
Feb 25, 2026	Eliana Merle	Barclays	Maintains	Hold	$24.00
Feb 25, 2026	Yigal Nochomovitz	Citi	Maintains	Strong Buy	$45.00 → $44.00 -1.00 (-2.2%)
Feb 25, 2026	Lisa Walter	RBC Capital	Maintains	Hold	$22.00 → $21.00 -1.00 (-4.5%)
Feb 25, 2026	Judah Frommer	Morgan Stanley	Maintains	Hold	$25.00
Feb 24, 2026	Steven Seedhouse	Cantor Fitzgerald	Maintains	Buy	$35.00
Feb 24, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	$45.00 → $40.00 -5.00 (-11.1%)
Feb 24, 2026	Tazeen Ahmad	BofA Securities	Reiterates	Buy	$28.00
Feb 24, 2026	Joseph Stringer	Needham	Maintains	Buy	$28.00
Feb 24, 2026	Lisa Walter	RBC Capital	Maintains	Hold	$22.00 → $21.00 -1.00 (-4.5%)
Jan 28, 2026	Eliana Merle	Barclays	Initiates	Hold	$24.00
Jan 21, 2026	Tazeen Ahmad	BofA Securities	Upgrades	Strong Buy	$28.00 → $28.00 +0.00 (0.0%)
Jan 20, 2026	Derek Archila	Wells Fargo	Maintains	Buy	$29.00 → $26.00 -3.00 (-10.3%)
Jan 14, 2026	Annabel Samimy	Stifel Nicolaus	Reiterates	Buy	$48.00
Jan 13, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Hold	$27.00
Jan 13, 2026	Steve Seedhouse	Cantor Fitzgerald	Maintains	Buy	$39.00 → $35.00 -4.00 (-10.3%)
Jan 13, 2026	Joseph Stringer	Needham	Maintains	Strong Buy	$29.00 → $28.00 -1.00 (-3.5%)
Jan 12, 2026	Steven Seedhouse	Cantor Fitzgerald	Maintains	Buy	$39.00 → $35.00 -4.00 (-10.3%)
Jan 12, 2026	Douglas Tsao	HC Wainwright	Reiterates	Buy	$45.00
Jan 12, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	$45.00
Jan 8, 2026	Lisa Walter	RBC Capital	Maintains	Hold	$22.00

Graig Suvannavejh

Mizuho

HoldMaintains

$20.00 → $41.00

Apr 2

Google Biotechnology

TipRanks - Google

BuyDowngrades

$18.00 → $44.00

Apr 1

PerPlexity Biotechnology

TipRanks - PerPlexity

HoldReiterates

$18.00 → $43.00

Apr 1

Anthropic Biotechnology

TipRanks - Anthropic

HoldReiterates

$17.50 → $44.00

Apr 1

OpenAI Biotechnology

TipRanks - OpenAI

HoldReiterates

$17.50 → $41.00

Apr 1

Steve Seedhouse

Cantor Fitzgerald

HoldDowngrades

Apr 1

Douglas Tsao

HC Wainwright

HoldDowngrades

$48.00 → $41.00

Apr 1

Eliana Merle

Barclays

HoldMaintains

$24.00 → $41.00

Apr 1

Anupam Rama

JP Morgan

HoldDowngrades

$37.00 → $41.00

Apr 1

Yigal Nochomovitz

Citi

HoldDowngrades

$44.00 → $41.00

Apr 1

Colleen M. Kusy

Baird

HoldUpgrades

$41.00

Apr 1

Ryan Deschner

Raymond James

HoldDowngrades

Apr 1

Steven Seedhouse

Cantor Fitzgerald

HoldUpgrades

$31.00

Mar 31

Lachlan Hanbury Brown

William Blair

HoldUpgrades

$40.00 → $41.00

Mar 31

Akash Tewari

Jefferies

HoldUpgrades

$41.00

Mar 31

Yigal Nochomovitz

Citi

HoldUpgrades

$44.00 → $41.00

Mar 31

Joseph Stringer

Needham

HoldDowngrades

Mar 31

Judah Frommer

Morgan Stanley

HoldInitiates Coverage

$25.00 → $41.00

Mar 31

Steve Seedhouse

Cantor Fitzgerald

BuyMaintains

$35.00 → $31.00

Mar 18

Adam Walsh

Roth Capital

Strong BuyInitiates

$31.00

Mar 13

Graig Suvannavejh

Mizuho

HoldMaintains

$19.00 → $20.00

Mar 5

Anupam Rama

JP Morgan

BuyMaintains

$36.00 → $37.00

Mar 5

Laura Chico

Wedbush

HoldMaintains

$20.00 → $18.00

Feb 25

Douglas Tsao

HC Wainwright

Strong BuyMaintains

$45.00 → $48.00

Feb 25

Eliana Merle

Barclays

HoldMaintains

$24.00

Feb 25

Yigal Nochomovitz

Citi

Strong BuyMaintains

$45.00 → $44.00

Feb 25

Lisa Walter

RBC Capital

HoldMaintains

$22.00 → $21.00

Feb 25

Judah Frommer

Morgan Stanley

HoldMaintains

$25.00

Feb 25

Steven Seedhouse

Cantor Fitzgerald

BuyMaintains

$35.00

Feb 24

Phil Nadeau

TD Cowen

BuyMaintains

$45.00 → $40.00

Feb 24

Tazeen Ahmad

BofA Securities

BuyReiterates

$28.00

Feb 24

Joseph Stringer

Needham

BuyMaintains

$28.00

Feb 24

Lisa Walter

RBC Capital

HoldMaintains

$22.00 → $21.00

Feb 24

Eliana Merle

Barclays

HoldInitiates

$24.00

Jan 28

Tazeen Ahmad

BofA Securities

Strong BuyUpgrades

$28.00 → $28.00

Jan 21

Derek Archila

Wells Fargo

BuyMaintains

$29.00 → $26.00

Jan 20

Annabel Samimy

Stifel Nicolaus

BuyReiterates

$48.00

Jan 14

OpenAI Biotechnology

TipRanks - OpenAI

HoldReiterates

$27.00

Jan 13

Steve Seedhouse

Cantor Fitzgerald

BuyMaintains

$39.00 → $35.00

Jan 13

Joseph Stringer

Needham

Strong BuyMaintains

$29.00 → $28.00

Jan 13

Steven Seedhouse

Cantor Fitzgerald

BuyMaintains

$39.00 → $35.00

Jan 12

Douglas Tsao

HC Wainwright

BuyReiterates

$45.00

Jan 12

Phil Nadeau

TD Cowen

BuyMaintains

$45.00

Jan 12

Lisa Walter

RBC Capital

HoldMaintains

$22.00

Jan 8

Apellis Pharmaceuticals, Inc. (APLS) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest APLS Analyst Ratings & Recommendations

Frequently Asked Questions